查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576807

基因編輯市場：按技術、應用、最終用戶、產品和服務、交付方式分類 - 2025-2030 年全球預測

Gene Editing Market by Technology (CRISPR, Meganucleases, TALENs), Application (Agricultural Applications, Clinical Applications, Research Applications), End User, Product & Service, Delivery Method - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年基因編輯市值為78.9億美元，預計2024年將達到91.8億美元，複合年成長率為17.81%，到2030年將達到248.7億美元。

基因編輯被定義為一種對生物體DNA序列進行特定且有意改變的方法，其精確性、效率和廣泛的應用在各個領域具有巨大的潛力。對基因編輯的需求源於其解決重要挑戰的能力，例如糾正遺傳疾病、提高農業生產力以及開發醫療保健領域的新治療方法。其應用領域廣泛，從生物醫學研究、農業、藥物發現到再生醫學，使其成為現代科學的多功能工具。最終用途廣泛，包括製藥、生物技術、農業和學術研究機構。市場成長的推動因素包括 CRISPR-Cas9 等基因編輯技術的進步、公共和私人資金的增加以及對基因改造作物和基因療法的需求不斷成長。然而，道德問題、監管挑戰和高成本是限制快速市場滲透的主要限制因素。此外，CRISPR技術的複雜性和脫靶效應帶來了阻礙廣泛採用的技術挑戰。重大機會在於將應用從傳統應用擴展到合成生物學和生質燃料等領域。為了利用這些潛在的機會，公司應該專注於降低成本並提高基因編輯技術的精確度的創新，從而提高其適用性和社會接受度。人工智慧和機器學習相結合來預測基因編輯的結果，以及 CRISPR 文庫加速研究的潛力，為創新提供了一個有前景的領域。然而，監管情況因地區而異，因此需要策略導航才能更順利地進入和採用市場。市場競爭激烈，技術進步迅速，需要不斷創新。因此，公共當局、私人公司和監管機構之間的廣泛合作對於充分發揮基因編輯技術的潛力並指導道德實施至關重要。

主要市場統計
基準年[2023] 78.9億美元
預測年份 [2024] 91.8億美元
預測年份 [2030] 248.7億美元
複合年成長率（%） 17.81%

市場動態：揭示快速發展的基因編輯市場的關鍵市場洞察

供需的動態交互作用正在改變基因編輯市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 遺傳性疾病和病症的盛行率日益增加，需要創新的治療解決方案
    • 擴大 CRISPR 和其他先進技術在臨床應用中的採用
    • 擴大政府和私營部門對基因組學和基因治療研究的資助
  • 市場限制因素
    • 基因編輯技術的高成本和倫理問題
  • 市場機會
    • 將基因編輯與人工智慧（AI）等其他先進技術結合
    • 增加基因研究和生物技術的投資，推動基因編輯的進步
  • 市場挑戰
    • 與基因編輯相關的技術和倫理問題

波特的五力：駕馭基因編輯市場的策略工具

波特的五力架構是了解基因編輯市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因編輯市場的外部影響

外部宏觀環境因素在塑造基因編輯市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因編輯市場的競爭狀況

對基因編輯市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV定位矩陣基因編輯市場廠商績效評估

FPNV定位矩陣是評估基因編輯市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了基因編輯市場的成功之路

基因編輯市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 越來越多的遺傳疾病和病症需要創新治療方法
      • 更多在臨床應用中採用 CRISPR 和其他先進技術
      • 擴大政府和私營部門對基因組學和基因治療研究的資助
    • 抑制因素
      • 基因編輯技術的高成本和倫理問題
    • 機會
      • 將基因編輯與人工智慧（AI）等其他先進技術結合
      • 對基因研究和生物技術的投資增加推動了基因編輯的進步
    • 任務
      • 與基因編輯相關的技術和倫理挑戰
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基因編輯市場：依技術分類

  • 更脆
  • Meganucleases
  • TALENs
  • 鋅指核酸酶 (ZFN)

第7章 基因編輯市場：依應用分類

  • 農業用途
    • 作物改良
    • 家畜基因工程
  • 臨床應用
    • 細胞株工程
    • 基因治療
  • 調查申請
    • 基因功能研究
    • 幹細胞研究

第8章 基因編輯市場：依最終使用者分類

  • 學術研究所
  • 合約調查機構
  • 製藥和生物技術公司

第9章基因編輯市場：依產品/服務分類

  • 消耗品
    • 試劑套件和試劑
    • 圖書館
  • 裝置
  • 服務

第10章按交付方式分類的基因編輯市場

  • 生物學方法
    • 非病毒方法
    • 病毒載體
  • 物理方法
    • 電穿孔
    • 顯微注射

第11章美洲基因編輯市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區基因編輯市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲基因編輯市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-535C6291877E

The Gene Editing Market was valued at USD 7.89 billion in 2023, expected to reach USD 9.18 billion in 2024, and is projected to grow at a CAGR of 17.81%, to USD 24.87 billion by 2030.

Gene editing, defined as a method of making specific and intentional changes to the DNA sequence of living organisms, holds immense potential across various sectors due to its precision, efficiency, and broad application scope. The necessity of gene editing is rooted in its ability to address critical challenges, such as correcting genetic disorders, improving agricultural productivity, and developing novel therapies in healthcare. Applications span sectors from biomedical research, agriculture, and drug discovery to regenerative medicine, making it a versatile tool in modern science. End-use scope is vast, including pharmaceuticals, biotechnology, agriculture, and academic research institutions. Market growth is driven by advances in gene-editing technologies like CRISPR-Cas9, increased funding from public and private sectors, and an escalating demand for genetically modified crops and gene therapies. However, ethical concerns, regulatory challenges, and high costs are significant limitations curbing rapid market adoption. Moreover, the complexity of CRISPR technology and off-target effects present technical challenges that hinder widespread use. Key opportunities lie in expanding applications beyond traditional uses to encompass areas like synthetic biology and biofuels. To capitalize on these potential opportunities, businesses should focus on innovations that reduce costs and improve the precision of gene-editing techniques, thus enhancing their applicability and public acceptance. The integration of artificial intelligence and machine learning to predict gene-edited outcomes and potential CRISPR libraries to expedite research offer promising areas of innovation. However, stringent regulatory landscapes across different regions necessitate strategic navigation to enable smoother market entry and adoption. The gene editing market is intensely competitive, characterized by rapid technological advancements and a need for constant innovation. Thus, widespread collaboration between public institutions, private players, and regulatory bodies is essential to harness the full potential and guide ethical implementation of gene-editing technologies.

KEY MARKET STATISTICS
Base Year [2023] USD 7.89 billion
Estimated Year [2024] USD 9.18 billion
Forecast Year [2030] USD 24.87 billion
CAGR (%) 17.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Editing Market

The Gene Editing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased prevalence of genetic diseases and disorders requiring innovative treatment solutions
    • Growing adoption of CRISPR and other advanced technologies in clinical applications
    • Expanding governmental and private sector funding for genomics and gene therapy research
  • Market Restraints
    • High costs and ethical concerns regarding gene-editing technologies
  • Market Opportunities
    • Integration of gene editing with other advanced technologies such as artificial intelligence (AI)
    • Rising investment in genetic research and biotechnology to drive gene editing advancements
  • Market Challenges
    • Technological and ethical challenges associated with gene editing

Porter's Five Forces: A Strategic Tool for Navigating the Gene Editing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Editing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Editing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Editing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Editing Market

A detailed market share analysis in the Gene Editing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Editing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Editing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Editing Market

A strategic analysis of the Gene Editing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Bayer CropScience, Beam Therapeutics, Bluebird Bio, Caribou Biosciences, Cellectis, Cibus, CRISPR Therapeutics, Editas Medicine, Genscript Biotech, Horizon Discovery, Inscripta, Intellia Therapeutics, Lonza Group, Pioneer Hi-Bred International Inc., Precision Biosciences, Regeneron Pharmaceuticals, Sangamo Therapeutics, Syngenta AG, Synthego, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across CRISPR, Meganucleases, TALENs, and Zinc Finger Nucleases (ZFNs).
  • Based on Application, market is studied across Agricultural Applications, Clinical Applications, and Research Applications. The Agricultural Applications is further studied across Crop Enhancement and Livestock Genetic Engineering. The Clinical Applications is further studied across Cell Line Engineering and Gene Therapy. The Research Applications is further studied across Gene Function Studies and Stem Cell Research.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Product & Service, market is studied across Consumables, Instruments, and Services. The Consumables is further studied across Kits & Reagents and Libraries.
  • Based on Delivery Method, market is studied across Biological Methods and Physical Methods. The Biological Methods is further studied across Non-Viral Methods and Viral Vectors. The Physical Methods is further studied across Electroporation and Microinjection.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased prevalence of genetic diseases and disorders requiring innovative treatment solutions
      • 5.1.1.2. Growing adoption of CRISPR and other advanced technologies in clinical applications
      • 5.1.1.3. Expanding governmental and private sector funding for genomics and gene therapy research
    • 5.1.2. Restraints
      • 5.1.2.1. High costs and ethical concerns regarding gene-editing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of gene editing with other advanced technologies such as artificial intelligence (AI)
      • 5.1.3.2. Rising investment in genetic research and biotechnology to drive gene editing advancements
    • 5.1.4. Challenges
      • 5.1.4.1. Technological and ethical challenges associated with gene editing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Editing Market, by Technology

  • 6.1. Introduction
  • 6.2. CRISPR
  • 6.3. Meganucleases
  • 6.4. TALENs
  • 6.5. Zinc Finger Nucleases (ZFNs)

7. Gene Editing Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural Applications
    • 7.2.1. Crop Enhancement
    • 7.2.2. Livestock Genetic Engineering
  • 7.3. Clinical Applications
    • 7.3.1. Cell Line Engineering
    • 7.3.2. Gene Therapy
  • 7.4. Research Applications
    • 7.4.1. Gene Function Studies
    • 7.4.2. Stem Cell Research

8. Gene Editing Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Contract Research Organizations
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Gene Editing Market, by Product & Service

  • 9.1. Introduction
  • 9.2. Consumables
    • 9.2.1. Kits & Reagents
    • 9.2.2. Libraries
  • 9.3. Instruments
  • 9.4. Services

10. Gene Editing Market, by Delivery Method

  • 10.1. Introduction
  • 10.2. Biological Methods
    • 10.2.1. Non-Viral Methods
    • 10.2.2. Viral Vectors
  • 10.3. Physical Methods
    • 10.3.1. Electroporation
    • 10.3.2. Microinjection

11. Americas Gene Editing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Gene Editing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Gene Editing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bayer CropScience
  • 2. Beam Therapeutics
  • 3. Bluebird Bio
  • 4. Caribou Biosciences
  • 5. Cellectis
  • 6. Cibus
  • 7. CRISPR Therapeutics
  • 8. Editas Medicine
  • 9. Genscript Biotech
  • 10. Horizon Discovery
  • 11. Inscripta
  • 12. Intellia Therapeutics
  • 13. Lonza Group
  • 14. Pioneer Hi-Bred International Inc.
  • 15. Precision Biosciences
  • 16. Regeneron Pharmaceuticals
  • 17. Sangamo Therapeutics
  • 18. Syngenta AG
  • 19. Synthego
  • 20. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. GENE EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. GENE EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE EDITING MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE EDITING MARKET SIZE, BY MEGANUCLEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE EDITING MARKET SIZE, BY TALENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE EDITING MARKET SIZE, BY ZINC FINGER NUCLEASES (ZFNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE EDITING MARKET SIZE, BY CROP ENHANCEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE EDITING MARKET SIZE, BY LIVESTOCK GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE EDITING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE EDITING MARKET SIZE, BY GENE FUNCTION STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE EDITING MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENE EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENE EDITING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GENE EDITING MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GENE EDITING MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GENE EDITING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GENE EDITING MARKET SIZE, BY NON-VIRAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GENE EDITING MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GENE EDITING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GENE EDITING MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES GENE EDITING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 202. SINGAPORE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 224. TAIWAN GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 235. THAILAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 246. VIETNAM GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 249. VIETNAM GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 269. DENMARK GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. DENMARK GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. DENMARK GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 272. DENMARK GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 280. EGYPT GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. EGYPT GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. EGYPT GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. EGYPT GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 291. FINLAND GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 292. FINLAND GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. FINLAND GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. FINLAND GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 295. FINLAND GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 296. FINLAND GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 302. FRANCE GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. FRANCE GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. FRANCE GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 305. FRANCE GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 306. FRANCE GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 307. FRANCE GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. FRANCE GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 313. GERMANY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 314. GERMANY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. GERMANY GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 316. GERMANY GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 317. GERMANY GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 318. GERMANY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 319. GERMANY GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 322. GERMANY GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 323. GERMANY GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 324. ISRAEL GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 325. ISRAEL GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. ISRAEL GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 327. ISRAEL GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 328. ISRAEL GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 329. ISRAEL GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 330. ISRAEL GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 331. ISRAEL GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 332. ISRAEL GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 333. ISRAEL GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 334. ISRAEL GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 335. ITALY GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 336. ITALY GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 337. ITALY GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 338. ITALY GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 339. ITALY GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 340. ITALY GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 341. ITALY GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 342. ITALY GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 343. ITALY GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 344. ITALY GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 345. ITALY GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 346. NETHERLANDS GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 347. NETHERLANDS GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 348. NETHERLANDS GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 349. NETHERLANDS GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 350. NETHERLANDS GENE EDITING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 351. NETHERLANDS GENE EDITING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 352. NETHERLANDS GENE EDITING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 353. NETHERLANDS GENE EDITING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 354. NETHERLANDS GENE EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
  • TABLE 355. NETHERLANDS GENE EDITING MARKET SIZE, BY BIOLOGICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 356. NETHERLANDS GENE EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2030 (USD MILLION)
  • TABLE 357. NIGERIA GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 358. NIGERIA GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 359. NIGERIA GENE EDITING MARKET SIZE, BY AGRICULTURAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 360. NIGERIA GENE EDITING MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2